US 8012699
Recombinant antigens for diagnosis and prevention of murine typhus
granted A61KA61K39/0233A61P
Quick answer
US patent 8012699 (Recombinant antigens for diagnosis and prevention of murine typhus) held by United States of America as represented by the Secretary of the Air Force expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Air Force
- Grant date
- Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K39/0233, A61P, A61P31/04